Clinical Trial Update: Anti-inflammatory Effects of Tiotropium in Patients with Stable COPD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating anti-inflammatory effects of tiotropium in patients with stable chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Spiriva (tiotropium) (tiotropium)

Snippet

Sponsor: University Medical Center Groningen | Conditions: COPD | Phase 4 | Status: COMPLETED